Osaic Holdings’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $629K | Buy |
9,488
+899
| +10% | +$59.6K | ﹤0.01% | 2613 |
|
|
2025
Q1 | $545K | Sell |
8,589
-519
| -6% | -$32.9K | ﹤0.01% | 2779 |
|
|
2024
Q4 | $606K | Sell |
9,108
-2,974
| -25% | -$198K | ﹤0.01% | 2608 |
|
|
2024
Q3 | $844K | Buy |
12,082
+147
| +1% | +$10.3K | ﹤0.01% | 2394 |
|
|
2024
Q2 | $773K | Sell |
11,935
-3,788
| -24% | -$245K | ﹤0.01% | 2401 |
|
|
2024
Q1 | $1.02M | Buy |
15,723
+279
| +2% | +$18.1K | ﹤0.01% | 2308 |
|
|
2023
Q4 | $1.02M | Sell |
15,444
-6,237
| -29% | -$411K | ﹤0.01% | 2493 |
|
|
2023
Q3 | $1.24M | Buy |
21,681
+4,758
| +28% | +$271K | ﹤0.01% | 2438 |
|
|
2023
Q2 | $1.04M | Buy |
16,923
+715
| +4% | +$43.8K | ﹤0.01% | 2491 |
|
|
2023
Q1 | $1.02M | Sell |
16,208
-95
| -0.6% | -$5.97K | ﹤0.01% | 2451 |
|
|
2022
Q4 | $1.03M | Buy |
16,303
+714
| +5% | +$45.3K | ﹤0.01% | 2332 |
|
|
2022
Q3 | $919K | Buy |
15,589
+323
| +2% | +$19K | ﹤0.01% | 2314 |
|
|
2022
Q2 | $884K | Buy |
15,266
+264
| +2% | +$15.3K | ﹤0.01% | 2399 |
|
|
2022
Q1 | $861K | Sell |
15,002
-18,564
| -55% | -$1.07M | ﹤0.01% | 2717 |
|
|
2021
Q4 | $2.39M | Sell |
33,566
-9,034
| -21% | -$644K | ﹤0.01% | 1628 |
|
|
2021
Q3 | $3.19M | Sell |
42,600
-47
| -0.1% | -$3.52K | 0.01% | 1361 |
|
|
2021
Q2 | $3.3M | Sell |
42,647
-3,725
| -8% | -$288K | 0.01% | 1324 |
|
|
2021
Q1 | $3.43M | Buy |
46,372
+2,529
| +6% | +$187K | 0.01% | 1193 |
|
|
2020
Q4 | $3.07M | Buy |
43,843
+3,292
| +8% | +$231K | 0.01% | 1147 |
|
|
2020
Q3 | $2.3M | Buy |
40,551
+59
| +0.1% | +$3.34K | 0.01% | 1223 |
|
|
2020
Q2 | $2.36M | Sell |
40,492
-28,255
| -41% | -$1.65M | 0.01% | 1156 |
|
|
2020
Q1 | $3.2M | Buy |
+68,747
| New | +$3.2M | 0.01% | 805 |
|